Viruses 2010, 2(8), 1766-1781; doi:10.3390/v2081766

Antiviral Strategies for Pandemic and Seasonal Influenza

email, email and * email
Received: 11 June 2010; in revised form: 6 August 2010 / Accepted: 11 August 2010 / Published: 20 August 2010
(This article belongs to the Special Issue Antivirals Against Influenza)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: While vaccines are the primary public health response to seasonal and pandemic flu, short of a universal vaccine there are inherent limitations to this approach. Antiviral drugs provide valuable alternative options for treatment and prophylaxis of influenza. Here, we will review drugs and drug candidates against influenza with an emphasis on the recent progress of a host-targeting entry-blocker drug candidate, DAS181, a sialidase fusion protein.
Keywords: influenza virus; neuraminidase inhibitors; sialic acid; RNA polymerase
PDF Full-text Download PDF Full-Text [259 KB, uploaded 20 August 2010 17:34 CEST]

Export to BibTeX |

MDPI and ACS Style

Hedlund, M.; Larson, J.L.; Fang, F. Antiviral Strategies for Pandemic and Seasonal Influenza. Viruses 2010, 2, 1766-1781.

AMA Style

Hedlund M, Larson JL, Fang F. Antiviral Strategies for Pandemic and Seasonal Influenza. Viruses. 2010; 2(8):1766-1781.

Chicago/Turabian Style

Hedlund, Maria; Larson, Jeffrey L.; Fang, Fang. 2010. "Antiviral Strategies for Pandemic and Seasonal Influenza." Viruses 2, no. 8: 1766-1781.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert